Well, that was fast.
It's safe to say that FAA won’t be offering any flimsy show-cause explanation as to why it didn’t conduct a final regulatory flexibility analysis on its drug and alcohol rule. The agency went one better—providing said analysis in a Federal Register notice published Tuesday.
Using ARSA survey data to help set a baseline, FAA determined that companies with at least 25 employees and $750,000-$2 million in revenue would pay about $13,000 if they had to comply by the rule. Continued the agency:
The FAA is aware that a substantial number of small entities must comply with this rule; however, the percentage of cost to revenue is less that 1 percent, therefore we believe that this rule does not have a significant economic impact. Therefore the FAA preliminarily certifies that this rule will not have a significant economic impact on a substantial number of small entities.
ARSA acknowledged the filing and said in a release issued late Tuesday that it will "issue a robust and detailed response once we have processed the information."